The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy

Background: The treatment choice for completely resected stage IIIA/N2 non-small cell lung cancer (NSCLC) patients is still controversial now. Our study aims to identify potential prognostic factors in stage IIIA/N2 NSCLC patients with complete surgical resection and postoperative chemotherapy. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hui, Wang, Kunlun, Li, Shenglei, Li, Yan, Yuan, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382988/
https://www.ncbi.nlm.nih.gov/pubmed/34447289
http://dx.doi.org/10.3389/pore.2021.1609898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382988/
https://www.ncbi.nlm.nih.gov/pubmed/34447289
http://dx.doi.org/10.3389/pore.2021.1609898

Ejemplares similares